ARCHIVES

NCI disclosure of walk-out by Data and Safety Monitoring Board of the National Lung Screening Trial may be harmful, improper, experts say.

This article is from The Cancer Letter archive.

Vol. 30 No. 16 | April 16, 2004

Download PDF Visit The Full Archive

Related Articles

NCI Plans $175 Million In Program Cuts To Cover Deficit, Fund New Initiatives

November 17, 2006

Tumor Cells In Blood May Indicate Aggressive Cancer

April 25, 2003

Regular NSAIDs Use Protects Smokers From Lung Cancer

March 28, 2003

Researchers Link Cancer Risk And DMPA Birth Control Use

April 27, 2012

Under A Flat Budget, NIH Suspends Grant Increases, May restore Funds Later.

November 24, 2000

University Of Illinois Cancer Center Director Kruh Dies

January 7, 2011